Patents for C12R 1 - Micro-organisms (92,025) |
---|
06/13/2001 | EP1105506A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
06/13/2001 | EP1105503A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE ALPHA1/BETA1 (hsGCALPHA1/BETA1) |
06/13/2001 | EP1105499A1 Transgenic microbial polyhydroxyalkanoate producers |
06/13/2001 | EP1105497A1 Cold-adapted equine influenza viruses |
06/13/2001 | EP1105479A2 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
06/13/2001 | EP1105477A1 Dcr5, a bmp-binding protein, and applications thereof |
06/13/2001 | EP1105471A2 CONSTRUCTION OF NORMALIZED cDNA LIBRARIES FROM EUCARYOTIC CELLS |
06/13/2001 | EP1105470A1 USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS |
06/13/2001 | EP1105468A2 A NOVEL PLASTID-TARGETING NUCLEIC ACID SEQUENCE, A NOVEL $g(b)-AMYLASE SEQUENCE, A STIMULUS-RESPONSIVE PROMOTER AND USES THEREOF |
06/13/2001 | EP1105466A1 Process for purifying human papillomavirus virus-like particles |
06/13/2001 | EP1105464A1 Human mesencephalon cell lines and methods of use therefor |
06/13/2001 | EP1105463A1 Cell population containing non-fetal hemangioblasts and method for producing same |
06/13/2001 | EP1105462A1 Engraftable human neural stem cells |
06/13/2001 | EP1105460A2 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof |
06/13/2001 | EP1105425A1 Monoclonal antibodies specific for streptococcus mutans, and uses thereof |
06/13/2001 | EP1105411A1 nrdE |
06/13/2001 | EP1105380A1 Process for the preparation of c-4 deacetyltaxanes |
06/13/2001 | EP1105157A1 Protein delivery system using human papillomavirus virus-like particles |
06/13/2001 | EP1105150A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
06/13/2001 | EP1105051A1 Collagen type i and type iii hemostatic compositions for use as a vascular sealant and wound dressing |
06/13/2001 | EP0789776B1 Nucleic acid transfer system |
06/13/2001 | EP0725798B1 Type i angiotensin ii receptor specific monoclonal antibodies and hybridoma |
06/13/2001 | DE19959650A1 Neue für die Gene sdhA, sdhB und sdhC codierende Nukleotidsequenzen New codes for genes SDHA, sdhB and sdhC nucleotide sequences |
06/13/2001 | DE19959582A1 Nukleinsäuren, die für neue Acetylcholinrezeptor-beta-Untereinheiten von Insekten kodieren Nucleic acids coding for new acetylcholine receptor beta subunits of insect |
06/13/2001 | DE19959329A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien A process for the fermentative preparation of L-amino acids using coryneform bacteria |
06/13/2001 | DE19959328A1 Neue für das zwa1-Gen codierende Nukleotidsequenzen New coding for the zwa1 gene nucleotide sequences |
06/13/2001 | DE19959327A1 Neue für das zwa2-Gen codierende Nukleotidsequenzen New coding for the zwa2 gene nucleotide sequences |
06/13/2001 | CN1299411A Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
06/13/2001 | CN1299272A Method and device for modulating the immune response |
06/13/2001 | CN1067104C Method for prepn. of secretion of hirudin derivatives |
06/12/2001 | US6245921 Process for the isolation of pseudomonic acid A from pseudomonic acid complex-containing culture broth |
06/12/2001 | US6245906 Probes for the diagnosis of infections caused by Streptococcus pyogenes |
06/12/2001 | US6245896 A polypeptide; diagnosis and therapy of endometriosis, antitumor/antiproliferative/anticarcinogenic agents; enhancing in situ fertilization |
06/12/2001 | US6245887 An isolated enzyme; for producing large quantities of c-terminal .alpha.-amidating enzyne |
06/12/2001 | US6245886 Peptides and peptidomimetics with structural similarity to human P53 that activate P53 function |
06/12/2001 | US6245739 polypeptides and polypeptide analogues |
06/12/2001 | US6245737 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
06/12/2001 | US6245546 Animal feed additives |
06/12/2001 | US6245545 Culturing a cell transformed with the vector comprising the isolated dna encoding the endonuclease of staphloccus warneri; used to cleave dna molecules into fragments for molecular cloning and gene characterization |
06/12/2001 | US6245536 Culturing rhodotorula using extract of soybeans or germs of soybeans as nutrient and substrate |
06/12/2001 | US6245524 Phenylacetyl-CoA ligase from penicillium chrysogenum |
06/12/2001 | US6245504 Transducing phages of Actinomycetales |
06/12/2001 | US6245503 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
06/12/2001 | US6245365 Arachidonic acid |
06/12/2001 | US6245338 OMP26 antigen from Haemophilus influenzae |
06/12/2001 | US6245337 Haemophilus adherence and penetration proteins |
06/12/2001 | US6245333 Isolated protein processed to peptides which form complexes with HLA molecules |
06/12/2001 | US6245329 Method of inducing calcium flux in cells using mammalian thymokine protein |
06/12/2001 | US6245235 Butane/oxygen injection system results in substantially improved treatment of contaminated sites. pollutants such as chlorinated aliphatic hydrocarbons |
06/12/2001 | CA2173595C Dna encoding prostaglandin receptor ip |
06/12/2001 | CA2126250C Method, reagents and kits for the detection of neisseria gonorrhoeae |
06/12/2001 | CA2117477C Multivalent single chain antibodies |
06/12/2001 | CA2092717C Expression of g protein coupled receptors in yeast |
06/12/2001 | CA2060505C Method for recovering recombinant proteins |
06/12/2001 | CA2050058C Recombinant mite allergen |
06/12/2001 | CA1341249C Expression and purification of an htlv-iii gag/env gene protein |
06/10/2001 | CA2326730A1 Novel nucleotide sequences coding for the genes sdha, sdhb and sdhc |
06/09/2001 | CA2325766A1 Novel nucleotide sequences coding for the zwa2 gene |
06/09/2001 | CA2325593A1 Process for the fermentative preparation of l-amino acids using coryneform bacteria |
06/07/2001 | WO2001040499A2 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
06/07/2001 | WO2001040497A2 Method for obtaining nucleic acids from an environment sample |
06/07/2001 | WO2001040489A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
06/07/2001 | WO2001011064A3 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
06/07/2001 | US20010003046 Process for preparing (S)-3-halogeno-1,2-propanediol by microorganism |
06/07/2001 | DE19958160A1 Neue für das gpm-Gen codierende Nukleotidsequenzen New coding for the gpm gene nucleotide sequences |
06/07/2001 | DE19958159A1 Neue für das glk-Gen codierende Nukleotidsequenzen New coding for the glk gene nucleotide sequences |
06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
06/06/2001 | EP1104812A1 Nucleotide sequences coding for the gpm gene |
06/06/2001 | EP1104810A1 Method for the fermentative production of L-lysine using coryneform bacteria |
06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
06/06/2001 | EP1104807A2 Apparatus for the production of TGF-beta |
06/06/2001 | EP1104484A2 Composition and methods for exposing antigenic epitopes on cultured microorganisms |
06/06/2001 | EP1104482A2 Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins |
06/06/2001 | EP1104480A1 Polynucleotide sequences |
06/06/2001 | EP1104477A1 Increasing stearate content in soybean oil by expression of acyl-acp thioesterase |
06/06/2001 | EP1104476A1 Nucleotide and/or amino-acid sequence controlling the expression of a xylanase promoter-operator nucleotide sequence |
06/06/2001 | EP1104472A1 Gene switch |
06/06/2001 | EP1104471A2 Pesticidal toxins and genes from bacillus laterosporus strains |
06/06/2001 | EP1104468A1 Genetic method for the expression of polyproteins in plants |
06/06/2001 | EP1104464A2 Nucleic acids encoding a functional human purinoreceptor p2x2 and methods of producing and use thereof |
06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
06/06/2001 | EP1104458A1 Methods for purifying non-chromosomal nucleic acid molecules from cells |
06/06/2001 | EP1104457A1 Method for obtaining in vitro recombined polynucleotide sequences, sequence banks and resulting sequences |
06/06/2001 | EP1104281A1 Incorporation of exogenous lactic bacteria into the oral microflora |
06/06/2001 | EP1104231A1 Biodegradable high oxidative stability oils |
06/06/2001 | EP1083234A9 Process for producing l-ribose |
06/06/2001 | EP0839211B1 Riboflavin-production process by means of micro-organisms with modified isocitratlyase activity |
06/06/2001 | EP0673426B1 Platelet-activating factor acetylhydrolase |
06/06/2001 | EP0504349B1 BIOCONVERSIONS CATALYZED BY THE TOLUENE MONOOXYGENASE OF $i(PSEUDOMONAS MENDOCINA) KR-1 |
06/06/2001 | CN1298453A Process for preparing doxorubicin |
06/06/2001 | CN1298452A Method for the biotechnological oxidation of substituted trimethylcyclohexenyl compounds |
06/06/2001 | CN1298448A Microbial preparation of substances from aromatic metabolism /III |
06/06/2001 | CN1298412A G-CSF receptor agonist antibodies and screening method therefor |
06/06/2001 | CN1298308A Inhibitors of complement activation |
06/06/2001 | CN1298019A New nucleotide sequence of coded gene sucC and sucD |
06/05/2001 | US6242582 Method of detection of influenza virus and compounds for use therein |
06/05/2001 | US6242566 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
06/05/2001 | US6242255 Protein which induces interferon-gamma production by immunocompetent cell |
06/05/2001 | US6242254 Cell has dna encoding tetracycline responsive transcriptional activator linked to tissue-specific promoter and tetracycline operator minimal promoter linked to dna encoding sv40 t antigen; cell proliferation is controlled by tetracycline |